Publications by authors named "I Huhtaniemi"

Article Synopsis
  • The study investigates the expression and functionality of follicle-stimulating hormone receptor (FSHR) in human myometrium (uterine muscle) and adipose tissue (fat) during both non-pregnant and pregnant states, as well as its connection to uterine activity and fat thermogenesis.
  • Using various methods to evaluate FSHR expression and treatment effects, the researchers found no FSHR expression in these tissues, contradicting prior studies.
  • The results indicate that FSHR signaling does not play a role in regulating uterine contraction or influencing adipose tissue activities, casting doubt on previous assumptions about FSHR's functionality in these areas
View Article and Find Full Text PDF

Zona pellucida 3 (ZP3) expression is classically found in the ZP-layer of the oocytes, lately shown in ovarian and prostate cancer. A successful ZP3 ovarian cancer immunotherapy in transgenic mice suggested its use as an attractive therapeutic target. The biological role of ZP3 in cancer growth and progression is still unknown.

View Article and Find Full Text PDF

The role of estradiol (E2; an estrogen) in men needs to be more appreciated. In this review, we address the clinical situations that allow the study of the clinical consequences of E2 deficiency in men and discuss the effects of restoration of levels of this reproductive steroid hormone. In men with advanced prostate cancer (PCa) undergoing androgen deprivation therapy (ADT), E2 is suppressed along with testosterone, leading to side effects affecting the quality of life.

View Article and Find Full Text PDF

Empirical evidence for a low normal or reference interval for serum prolactin (PRL) is lacking for men, while the implications of very low PRL levels for human health have never been studied. A clinical state of "PRL deficiency" has not been defined except in relation to lactation. Using data from the European Male Ageing Study (EMAS), we analyzed the distribution of PRL in 3,369 community-dwelling European men, aged 40-80 years at phase-1 and free from acute illnesses.

View Article and Find Full Text PDF

Insulin-like peptide 3 (INSL3) is a circulating biomarker for Leydig cell functional capacity in men, also indicating Leydig Cell Insufficiency (LCI) and potential primary hypogonadism. Using results from large cohort studies we explore sources of biological and technical variance, and establish a reference range for adult men. It is constitutively secreted with little within-individual variation and reflects testicular capacity to produce testosterone.

View Article and Find Full Text PDF